Find your next paid study

University of VirginiaNCT07405645

Actual pay is set by the research site.

HypoglycemiaType 1 Diabetes

On the Regulation of Hepatic Glucose Metabolism During Insulin-induced Hypoglycemia

Iatrogenic hypoglycemia is the most prominent barrier to the safe, effective management of blood sugar in people with type 1 diabetes due to periodic over-insu…

University of CincinnatiNCT06470295

~$500 – $6,750

Actual pay is set by the research site.

Head and Neck CancerLocally Advanced Head and Neck Carcinoma

Phase I/II Trial of Gabapentin Plus Ketamine for Prevention and Treatment of Acute and Chronic Pain in Locally Advanced Head and Neck Cancer Patients Undergoing Primary or Adjuvant Chemoradiation

This is a study to establish a safe and feasible dose for prophylactic use of a combination of gabapentin and ketamine in head and neck cancer patients undergo…

Natalie LockneyNCT05156060

~$150 – $4,500

Actual pay is set by the research site.

A Proposal to Establish the Mississippi Violence Injury Prevention (VIP) Program

This clinical trial is designed to evaluate the effectiveness of three interventions aimed at preventing violence and supporting those affected by it. Over nex…

Gun Shot Wound

University of Mississippi Medical CenterNCT06736730

Actual pay is set by the research site.

Phase 3

Melatonin for the Prevention of Antibiotic Associated Acute Kidney Injury

This study will evaluate the safety and effectiveness of melatonin for the prevention of antibiotic associated acute kidney injury in hospitalized patients.

Acute Kidney InjuryAdverse Drug Event

Rutgers, The State University of New JerseyNCT05084196

~$50 – $1,500

Actual pay is set by the research site.

Ovarian CancerSolid Tumor

A Phase 1, First-in-Human Study of CUSP06, a Cadherin-6 (CDH6)-Directed Antibody-Drug Conjugate, in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

This phase 1 study will evaluate the safety, tolerability, pharmacokinetics, and efficacy of CUSP06 in patients with platinum-refractory/resistant ovarian canc…

OnCusp Therapeutics, Inc.NCT06234423

~$150 – $4,200

Actual pay is set by the research site.

Mild Traumatic Brain Injury, Concussion

Advancement of Vestibular Intervention Via Portable Electrical Stimulator (VIPES)

The goal is to assess the potential benefit of stochastic galvanic vestibular stimulation (sGVS) in improving patient performance with respect to balance, gait…

Vivonics, Inc.NCT07466589

~$10 – $1,050

Actual pay is set by the research site.

Exploratory Next Generation Sequencing to Identify Causative Variants for Bevacizumab-Induced Hypertension From Breast Cancer Study E5103 Germline DNA Samples

This research trial studies whole exome sequencing in finding causative variants in germline deoxyribonucleic acid (DNA) samples from patients with hypertensio…

Breast Carcinoma

National Cancer Institute (NCI)NCT02610413

~$10 – $675

Actual pay is set by the research site.

Effectiveness and Implementation of a Brief Motivational Intervention to Increase Physical Activity for World Trade Center Health Program Cancer Survivors

The goal of this study is to test a brief motivational intervention to increase physical activity in a group of cancer survivors who are participants in the Wo…

Cancer

Stony Brook UniversityNCT07215091

Actual pay is set by the research site.

Breast CancerLocally Advanced Breast CancerNeoadjuvant Chemotherapy+3 more

Contrast Enhanced Digital Mammography for Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy

The purpose of this study is to compare a special type of mammogram that uses a contrast agent called contrast-enhanced digital mammography with contrast-enhan…

Alison StopeckNCT06220214

~$150 – $4,500

Actual pay is set by the research site.

Ewing SarcomaRhabdomyosarcomaWilms Tumor+3 more

A Phase I Study of Vorinostat in Combination With Vincristine, Irinotecan, and Temozolomide in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Tumors and CNS Malignancies

Investigators are testing new experimental drug combinations such as the combination of vorinostat, vincristine, irinotecan, and temozolomide in the hopes of f…

New York Medical CollegeNCT04308330

~$150 – $3,000

Actual pay is set by the research site.

Effects of Resistance Exercise Among TGD Individuals Initiating Estrogen-Based Gender-Affirming Hormone Therapy

Estrogen-dominant gender-affirming hormone therapy (GAHT) is standard of care for transgender women and gender-diverse individuals and typically consists of es…

Muscle Mass and Strength